Cutler Group LP Aerie Pharmaceuticals Inc Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$6.37 - $15.23 $1,911 - $4,569	-300 Reduced 13.04%	2,000 $30,000
Q2 2022 Aug 04, 2022	SELL	$4.95 - $9.16 $1,485 - $2,748	-300 Reduced 11.54%	2,300 $17,000
Q4 2020 Jan 21, 2021	SELL	$9.12 - $14.49 $2,735 - $4,347	-300 Reduced 10.34%	2,600 $35,000
Q1 2020 May 07, 2020	BUY	$11.84 - $25.52 $29,600 - $63,800	2,500 Added 625.0%	2,900 $39,000
Q4 2018 Feb 05, 2019	SELL	$33.0 - $60.04 $3,300 - $6,004	-100 Reduced 20.0%	400 $14,000
Q3 2018 Nov 07, 2018	SELL	$56.15 - $73.9 $51,658 - $67,988	-920 Reduced 64.79%	500 $30,000
Q2 2018 Aug 10, 2018	SELL	$47.85 - $70.45 $446,057 - $656,734	-9,322 Reduced 86.78%	1,420 $95,000
Q4 2017 Jan 17, 2018	BUY	$50.85 - $65.1 $418,037 - $535,187	8,221 Added 326.1%	10,742 $641,000
Q3 2017 Oct 17, 2017	BUY	$48.6 - $60.1 $122,520 - $151,512	2,521	2,521 $122,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.